Vega Therapeutics Acquired by Incyte | Healthcare M&A Deal

Incyte has acquired Vega Therapeutics, a healthcare services other business in the United States. Incyte acquisitions focus on expanding oncology and drug development capabilities, while Vega Therapeutics works on advancing therapies for patients with serious diseases. The healthcare M&A transaction is categorized as an other acquisition and a strategic acquisition by Incyte to strengthen its pipeline and development platform. The deal is announced, with deal size undisclosed, and is expected to close subject to customary conditions and approvals.